Review
[Biopharmaceuticals in the treatment of rheumatoid arthritis]
[Article in
Danish]
Affiliations
- PMID: 18572481
Item in Clipboard
Review
[Biopharmaceuticals in the treatment of rheumatoid arthritis]
[Article in
Danish]
Ugeskr Laeger.
.
Abstract
The current status on the use of biopharmaceuticals in the treatment of rheumatoid arthritis is reviewed. Blocking of TNF-alpha, co-stimulation of CD28+ T-cells and depletion of CD20+ B-cells are all effective ways to diminish inflammation and joint damage. However, not all patients react to these treatments, and the development of biomarkers to predict which patients will benefit from these drugs is therefore warranted.
Similar articles
-
Safety and efficacy of rituximab in patients with rheumatoid arthritis refractory to disease modifying antirheumatic drugs and anti-tumor necrosis factor-alpha treatment.J Rheumatol. 2005 Nov;32(11):2109-15. J Rheumatol. 2005. PMID: 16265687 Clinical Trial.
-
Emerging biologic drugs for the treatment of rheumatoid arthritis.Autoimmun Rev. 2005 Nov;4(8):537-41. doi: 10.1016/j.autrev.2005.04.016. Autoimmun Rev. 2005. PMID: 16214092 Review.
-
[TNF-alpha antibody in rheumatoid arthritis. Efficacy-risk relationship is positively evaluated].MMW Fortschr Med. 2002 May 16;144(20):65. MMW Fortschr Med. 2002. PMID: 12119893 German. No abstract available.
-
Drugs for rheumatoid arthritis.Treat Guidel Med Lett. 2012 May;10(117):37-44; quiz 2 p following 44. Treat Guidel Med Lett. 2012. PMID: 22538522 Review. No abstract available.
-
Autoimmune diseases. The B cell slayer.Science. 2007 Nov 23;318(5854):1232-3. doi: 10.1126/science.318.5854.1232. Science. 2007. PMID: 18033858 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical